The federal agency introduced Elsa last month, boasting about the AI tool's ability to increase efficiency at the FDA.

But three of those FDA employees told CNN that Elsa just makes up nonexistent studies, something commonly referred to in AI ...

Loss of support staff has slowed critical investigations of drug manufacturers. Little relief has materialized.

Insiders tell CNN the FDA’s AI is “hallucinating” studies and can’t access key documents. Agency leaders insist the AI is getting better, and use is not mandatory.

FDA officials say the assistant is flawed, just as the Trump administration stresses AI adoption in healthcare.

The investigative unit, which looks into potential safety issues with drugs, vaccines, medical devices, and other products, has had a retention problem for years. Inspectors leave so often that, even ...

Around 3,500 FDA employees received termination emails; FDA Commissioner Marty Makary suggests lowering industry user fees ...

The U.S. Department of Health and Human Services is moving ahead with a plan to cut 10,000 jobs after the Supreme Court ...

In the first six months of 2025, 385 employees resigned from the Center for Drug Evaluation and Research, compared with under 130 staff during the same period last year.

Drugmaker Sarepta Therapeutics says it won't comply with a request from U.S. regulators to halt all shipments of its gene ...

During the regular morning devotion and flag ceremony on Monday, Infanta Mayor L.A. Ruanto signed Executive Order No. 10, ...

Policy FDA layoffs could compromise safety of medications made at foreign factories, inspectors say Beyond staff cuts, the departures of some longtime investigators in recent months have left less ...